Blog

We’re excited to announce that the ARI–Lilly Medication Therapy Management (MTM) MIND project is moving from planning to implementation! Over the past several months, the project team and expert advisors have worked together to develop patient education materials, pharmacist training resources, brain health tools, and implementation workflows designed to help adults ages 40-60 understand and address risk factors associated with dementia.

Update on the AMCP Research Institute Project: Advancing Coverage for Comprehensive Biomarker Testing in Non-Small Cell Lung Cancer (NSCLC): A LUNGevity and American Cancer Society Cancer Action Network (ACS CAN) Research Initiative.

Last week, AMCP Principal Research Scientist Pam Pawloski, PharmD, BCOP, FCCP, presented a project poster at ISPE 2026 in Milan, where she and Cate shared early findings and connected in person with our research collaborators from Italy and Denmark.

All 50 states have enacted some sort of pharmacy benefit manager (PBM) legislation, but a handful are setting the pace in terms of new laws targeting ownership restrictions, transparency requirements, and compensation models.

In June 2026, AMCP convened stakeholders across managed care, patient advocacy, life sciences, and research in Alexandria, VA, for its Partnership Forum, From Insights to Impact: Advancing the Use of Patient Experience Data (PED) in Payer Decision-Making.

If you’re interested in pursuing a career in managed care pharmacy, sitting in a classroom can only get you so far. AMCP chapter leadership bridges the gap between being a student and becoming a future healthcare leader, providing experience you can’t get through coursework. It gives you a safe space to test your ideas, make mistakes, and figure out who you want to be professionally.

AMCP members gathered in Washington, DC, on May 18–20 for Legislative Days 2026, to advocate for managed care's legislative priorities addressing patient access, affordability, and care delivery.

At the start of each year, AMCP brings together its Board, Foundation Officers, Committee & Affiliate leaders, and corporate partners for the Winter Leadership Meeting. It’s where we align on priorities, strengthen relationships, and ensure the work ahead reflects AMCP’s mission and trends and topics in managed care pharmacy.

Thousands of managed care pharmacy professionals from health plans, PBMs, pharmaceutical manufacturers, and other managed care organizations convened in National Harbor, MD, from Oct. 27-31 for AMCP Nexus 2025. Co-located at Nexus was our inaugural Pharmacy Policy Summit, which will continue to be held in the Washington, DC metropolitan area in years to come.

In managed care pharmacy, information moves quickly, and so do the professionals trying to keep up. Between evolving clinical guidelines, policy updates, and new therapies, it can be hard to stay current. That’s what makes podcasts such a refreshing space for learning – they turn education into something you can take with you.

In both of his administrations, President Trump promoted most-favored nation (MFN) pricing as a way to bring down drug costs in the United States. On July 31, 2025, President Trump sent letters to 17 pharmaceutical manufacturers demanding that they implement MFN prices or face the consequences.

On October 27, 2025, AMCP will host its inaugural Pharmacy Policy Summit at the Gaylord National Harbor. It is shaping up to be a must-attend event for anyone invested in the future of managed care pharmacy on the Hill and beyond.